Literature DB >> 8586198

Lipoprotein receptors in oral streptococci.

H F Jenkinson1, R McNab, D M Loach, G W Tannock.   

Abstract

Streptococcus gordonii produces cell-surface lipopolypeptides that have been implicated in the determination of cell adherence and aggregation properties. SarA lipopolypeptide produced by S. gordonii is highly similar to the oligopeptide-binding protein AmiA in Streptococcus pneumoniae and to the OppA and SpoOKA oligopeptide-binding proteins in Bacillus subtilis. Insertional mutagenesis was used to inactivate the genes encoding SarA (76kDa) lipoprotein and a related 78-kDa lipoprotein denoted SarG. SarA- mutants were defective in serum-induced aggregation, competence, growth on complex nitrogen sources, and ability to colonize the oral cavity. Conversely, SarG- mutants were unaltered in the above properties, but were deficient in growth on simple nitrogen sources. It is proposed that SarA plays a central role in environmental sensing of extracellular factors by streptococci leading to modulation of cell-surface composition and growth responses of cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586198

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  3 in total

1.  Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation.

Authors:  Hartmut Stoll; Jörn Dengjel; Christiane Nerz; Friedrich Götz
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  Identification of Virulence-Associated Properties by Comparative Genome Analysis of Streptococcus pneumoniae, S. pseudopneumoniae, S. mitis, Three S. oralis Subspecies, and S. infantis.

Authors:  Mogens Kilian; Hervé Tettelin
Journal:  mBio       Date:  2019-09-03       Impact factor: 7.867

3.  Identification of salivary mucin MUC7 binding proteins from Streptococcus gordonii.

Authors:  Mehmet Kesimer; Nedret Kiliç; Ravi Mehrotra; David J Thornton; John K Sheehan
Journal:  BMC Microbiol       Date:  2009-08-11       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.